Literature DB >> 18243112

The C-terminal regulatory domain is the RNA 5'-triphosphate sensor of RIG-I.

Sheng Cui1, Katharina Eisenächer, Axel Kirchhofer, Krzysztof Brzózka, Alfred Lammens, Katja Lammens, Takashi Fujita, Karl-Klaus Conzelmann, Anne Krug, Karl-Peter Hopfner.   

Abstract

The ATPase RIG-I senses viral RNAs that contain 5'-triphosphates in the cytoplasm. It initiates a signaling cascade that activates innate immune response by interferon and cytokine production, providing essential antiviral protection for the host. The mode of RNA 5'-triphosphate sensing by RIG-I remains elusive. We show that the C-terminal regulatory domain RD of RIG-I binds viral RNA in a 5'-triphosphate-dependent manner and activates the RIG-I ATPase by RNA-dependent dimerization. The crystal structure of RD reveals a zinc-binding domain that is structurally related to GDP/GTP exchange factors of Rab-like GTPases. The zinc coordination site is essential for RIG-I signaling and is also conserved in MDA5 and LGP2, suggesting related RD domains in all three enzymes. Structure-guided mutagenesis identifies a positively charged groove as likely 5'-triphosphate-binding site of RIG-I. This groove is distinct in MDA5 and LGP2, raising the possibility that RD confers ligand specificity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18243112     DOI: 10.1016/j.molcel.2007.10.032

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  271 in total

Review 1.  SF1 and SF2 helicases: family matters.

Authors:  Margaret E Fairman-Williams; Ulf-Peter Guenther; Eckhard Jankowsky
Journal:  Curr Opin Struct Biol       Date:  2010-04-22       Impact factor: 6.809

2.  Cooperative assembly and dynamic disassembly of MDA5 filaments for viral dsRNA recognition.

Authors:  Alys Peisley; Cecilie Lin; Bin Wu; McGhee Orme-Johnson; Mengyuan Liu; Thomas Walz; Sun Hur
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

3.  The RIG-I ATPase domain structure reveals insights into ATP-dependent antiviral signalling.

Authors:  Filiz Civril; Matthew Bennett; Manuela Moldt; Tobias Deimling; Gregor Witte; Stefan Schiesser; Thomas Carell; Karl-Peter Hopfner
Journal:  EMBO Rep       Date:  2011-10-28       Impact factor: 8.807

Review 4.  Pattern recognition of viral nucleic acids by RIG-I-like helicases.

Authors:  Andreas Schmidt; Stefan Endres; Simon Rothenfusser
Journal:  J Mol Med (Berl)       Date:  2010-09-04       Impact factor: 4.599

5.  Dissociation of paramyxovirus interferon evasion activities: universal and virus-specific requirements for conserved V protein amino acids in MDA5 interference.

Authors:  Aparna Ramachandran; Curt M Horvath
Journal:  J Virol       Date:  2010-08-18       Impact factor: 5.103

6.  Murine coronavirus induces type I interferon in oligodendrocytes through recognition by RIG-I and MDA5.

Authors:  Jianfeng Li; Yin Liu; Xuming Zhang
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

7.  Unpaired 5' ppp-nucleotides, as found in arenavirus double-stranded RNA panhandles, are not recognized by RIG-I.

Authors:  Jean-Baptiste Marq; Daniel Kolakofsky; Dominique Garcin
Journal:  J Biol Chem       Date:  2010-04-16       Impact factor: 5.157

8.  Phosphorylation of RIG-I by casein kinase II inhibits its antiviral response.

Authors:  Zhiguo Sun; Hongwei Ren; Yan Liu; Jessica L Teeling; Jun Gu
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

9.  USP4 positively regulates RIG-I-mediated antiviral response through deubiquitination and stabilization of RIG-I.

Authors:  Lijuan Wang; Wei Zhao; Meng Zhang; Peng Wang; Kai Zhao; Xueying Zhao; Shangru Yang; Chengjiang Gao
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

10.  Attenuation of rabies virus replication and virulence by picornavirus internal ribosome entry site elements.

Authors:  Adriane Marschalek; Stefan Finke; Martin Schwemmle; Daniel Mayer; Bernd Heimrich; Lothar Stitz; Karl-Klaus Conzelmann
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.